Staff

FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma

FDA approves Sarclisa® (isatuximab) in combination with carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma Sarclisa regimen...

Rapid Nutrition PLC (“Rapid Nutrition”, the “Company” or the “Group”) Annual Results; Evolving With Innovation and Insight to Deliver Sustainable Year-End Results

NEW YORK, NY / ACCESSWIRE / March 31, 2021 / Rapid Nutrition PLC (SW:RAP)(OTCQB:RPNRF), a natural wellness company dedicated to...

error: Content is protected !!